Optimized Conjugation Solution for Precise Extrahepatic Delivery of Small Nucleic Acid Drug, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn about conjugation methods, applications and clinical progress of small nucleic acid drug conjugates. Attendees will gain insight into the characterization of conjugated products using SDS-PAGE, CE-SDS, SEC, IEX and MS. The featured speaker will discuss how DAR1 conjugation strategies enhance the silencing efficiency and stability of conjugated products. The speaker will also share versatile conjugation solutions tailored to AOC/POC requirements, delivering high-purity conjugated products with precise silencing efficiency.

TORONTO, Oct. 14, 2025 /PRNewswire/ — Targeted delivery enhances the safety and efficacy of small nucleic acid drugs. By conjugating siRNA or antisense oligonucleotides (ASOs) with targeting molecules, such as antibodies or peptides, cellular uptake, stability and bioavailability are improved, while immunogenicity and toxicity are reduced.

In this webinar, the featured speakers will introduce technical solutions and application cases for small RNA drug conjugation, focusing on conjugate product identification, precise delivery and gene silencing, as well as differences across methods, offering new insights to boost research efficiency.

The topics that will be covered in this webinar include:

• Advances in Small Nucleic Acid Drug Delivery
• Ligand-Mediated Extrahepatic Delivery Techniques
• Advantages of DAR 1 Antibody-siRNA Conjugate
• Conjugation Solutions for Accelerating Precise Targeted Delivery

Register for this webinar to learn how conjugation strategies are shaping the future of small nucleic acid drug delivery.

Join Jacob Guo, PhD, Director, Nucleic Acid Platform, R&D Dept., GenScript Biotech Corporation, for the live webinar on Tuesday, October 28, 2025, at 2pm EDT (11am PDT).

For more information, or to register for this event, visit Optimized Conjugation Solution for Precise Extrahepatic Delivery of Small Nucleic Acid Drug.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/optimized-conjugation-solution-for-precise-extrahepatic-delivery-of-small-nucleic-acid-drug-upcoming-webinar-hosted-by-xtalks-302581995.html

SOURCE Xtalks